Additionally, several nicely founded adverse prognostic markers, which include U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their negative outcome in sufferers treated with VO. The one element that remained predictive of the shorter development-totally free survival in this cohort of clients was TP53 aberrations.112 Ultimately, the c